| BMC Medicine | |
| Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study | |
| Research Article | |
| Olivier Rollot1  Karim Boussaïd1  Corinne Mussard1  Adrian Fianu1  François Favier1  Patrick Gérardin2  Denis Malvy3  Alain Michault4  Bernard-Alex Gaüzere5  Gérard Bréart6  | |
| [1] Centre for Clinical Investigation-Clinical, Epidemiology (CIC-EC) of La Réunion (INSERM/CHR/URMLR), Saint Pierre, La Réunion, France;Centre for Clinical Investigation-Clinical, Epidemiology (CIC-EC) of La Réunion (INSERM/CHR/URMLR), Saint Pierre, La Réunion, France;Neonatal and Pediatric Intensive Care Unit, Centre Hospitalier Régional (CHR), Saint Pierre, La Réunion, France;UMR S953, 'Epidemiological Research on Perinatal Health and Women and Children Health', INSERM/Assistance Publique des Hôpitaux de Paris, Paris, France;Department of Internal Medicine and Tropical Diseases, Hôpital Saint André, Bordeaux, France;Microbiology, CHR, Saint Pierre, La Réunion, France;Polyvalent Intensive Care Unit, CHR, Saint Denis, La Réunion, France;UMR S953, 'Epidemiological Research on Perinatal Health and Women and Children Health', INSERM/Assistance Publique des Hôpitaux de Paris, Paris, France;Public Health Institute, INSERM, Paris, France; | |
| 关键词: Musculoskeletal Pain; Chikungunya; Chikungunya Virus; Hearing Difficulty; CHIKV Infection; | |
| DOI : 10.1186/1741-7015-9-5 | |
| received in 2010-08-16, accepted in 2011-01-14, 发布年份 2011 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundPersistent disabilities are key manifestations of Chikungunya virus (CHIKV) infection, especially incapacitating polyarthralgia and fatigue. So far, little is known about their impact on health status. The present study aimed at describing the burden of CHIKV prolonged or late-onset symptoms on the self-perceived health of La Réunion islanders.MethodsAt 18 months after an outbreak of Chikungunya virus, we implemented the TELECHIK survey; a retrospective cohort study conducted on a random sample of the representative SEROCHIK population-based survey. A total of 1,094 subjects sampled for CHIKV-specific IgG antibodies in the setting of La Réunion island in the Indian Ocean, between August 2006 and October 2006, were interviewed about current symptoms divided into musculoskeletal/rheumatic, fatigue, cerebral, sensorineural, digestive and dermatological categories.ResultsAt the time of interview, 43% of seropositive (CHIK+) subjects reported musculoskeletal pain (vs 17% of seronegative (CHIK-) subjects, P < 0.001), 54% fatigue (vs 46%, P = 0.04), 75% cerebral disorders (vs 57%, P < 0.001), 49% sensorineural impairments (vs 37%, P = 0.001), 18% digestive complaints (vs 15%, P = 0.21), and 36% skin involvement (vs 34%, P = 0.20) on average 2 years after infection (range: 15-34 months). After controlling for confounders such as age, gender, body mass index or major comorbidities in different Poisson regression models, 33% of joint pains were attributable to CHIKV, 10% of cerebral disorders and 7.5% of sensorineural impairments, while Chikungunya did not enhance fatigue states, digestive and skin disorders.ConclusionsOn average, 2 years after infection 43% to 75% of infected people reported prolonged or late-onset symptoms highly attributable to CHIKV. These manifestations carry a significant burden in the community in the fields of rheumatology, neurology and sensorineural health.
【 授权许可】
CC BY
© Gérardin et al; licensee BioMed Central Ltd. 2011
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311108559232ZK.pdf | 710KB |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
PDF